請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26781
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 符文美(Wen-Mei Fu) | |
dc.contributor.author | Tzeng-Ruei Lee | en |
dc.contributor.author | 李政叡 | zh_TW |
dc.date.accessioned | 2021-06-08T07:25:18Z | - |
dc.date.copyright | 2008-08-13 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-16 | |
dc.identifier.citation | Abeliovich A, Flint Beal M. (2006) Parkinsonism genes: culprits and clues. J Neurochem. 99:1062-1072
Abraham NG, Kappas A. (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 60:79-127. Adams RN, Murrill E, McCreery R, Blank L, Karolczak M (1972) 6-Hydroxydopamine, a new oxidation mechanism. Eur. J. Pharmacol. 17:287–292. Alam J and Zhining D (1992) Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267:21894–21900. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C. (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci U S A. 89:11347-11351. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 3:1301-1306. Bogaerts V, Theuns J, van Broeckhoven C. (2008) Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? Genes Brain Behav.7:129-151. Bonifati V., Rizzu P., van Baren M. J. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259. Bové J, Prou D, Perier C, Przedborski S. (2005) Toxin-induced models of Parkinson's disease. NeuroRx. 2:484-494. Brissaud, E. (1895) Nature et pathogenie de la maladie de Parkinson. Lecons Maladies Nerveuses 488–501. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 441:1162-1166. Deng H, Jankovic J, Guo Y, Xie W, Le W. (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 337:1133-1138. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381–389 Douglas MR, Lewthwaite AJ, Nicholl DJ. (2007) Genetics of Parkinson's disease and parkinsonism. Expert Rev Neurother. 7:657-666. Ehringer H, Hornykiewicz O. (1960) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 38:1236–1239. Fahn S and the Parkinson Study Group. (2005) Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol. 252 Suppl 4:IV37-IV42. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO. (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem. 275:3305-3312. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ. (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 1:515-525. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS, Fraser P, Cookson MR, Tandon A, Park DS. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A. 105:1716-1721. Hara MR, Agrawal N, Kim, SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A. (2005) S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 7:665-674. Hatano Y, Li Y, Sato K, Asakawa S, Yamamura Y, Tomiyama H, Yoshino H, Asahina M, Kobayashi S, Hassin-Baer S, Lu CS, Ng AR, Rosales RL, Shimizu N, Toda T, Mizuno Y, Hattori N. (2004) Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol. 56:424-427. Hengartner MO. (2000) The biochemistry of apoptosis. Nature. 407:770-776. Hughes AJ, Daniel SE, Blankson S, Lees AJ. (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 50:140-148. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang DM. (1996) An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther. 278:447-454. Jankovic J. (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 79:368-376. Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD. (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol. 32 Suppl:S82-87. Keyse SM and Tyrrell RM (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86:99–103. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:605-608. Klein C, Schlossmacher MG. (2006) The genetics of Parkinson disease: Implications for neurological care. Nat Clin Pract Neurol. 2:136-146. Kroemer G, Reed JC. (2000) Mitochondrial control of cell death. Nat Med. 6:513-519. Kutty RK, Nagieni CN, Kutty G, Hooks JJ, Chader GJ, and Wiggert B (1994) Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-β. J Cell Physiol 159:371–378. Lane JD, Lucocq J, Pryde J, Barr FA, Woodman PG, Allan VJ, Lowe M. (2002) Caspase-mediated cleavage of the stacking protein GRASP65 is required for Golgi fragmentation during apoptosis. J Cell Biol. 156:495-509. LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. (2005) Dopamine covalently modifies and functionally inactivates parkin. Nat Med. 11:1214-1221. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH. (1998) The ubiquitin pathway in Parkinson's disease. Nature. 395:451-452. Lutton JD, Levere RD, and Abraham NG (1991) Physiologic role of heme and cytochrome P-450 in hematopoietic cells. Proc Soc Exp Biol Med 196:260–269. Marras C, Lang A. (2008) Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain. Neurology. 70:1996-2003. Matsuura Y, Watanabe H, Fukuda T, Yoshida T, and Kuroiwa Y (1985) A sustained increase of microsomal heme oxygenase activity following treatment of rats with Bacillus Calmette-Gue´rin and Corynebacterium parvum: its possible relation to the decrease of cytochrome P-450 content. J Pharmacobiodyn 8:669–678. Mitani K, Fujita H, Sassa S, and Kappas A (1989) Heat shock induction of heme oxygenase mRNA in human Hep3B hepatoma cells. Biochem Biophys Res Commun 165:437–441. Mizuno Y, Suzuki K, Sone N, Saitoh T. (1987) Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains. Neurosci Lett. 81:204-208. Nascimento AL, Luscher P, and Tyrrell RM (1993) Ultraviolet A (320–380 nm) radiation causes an alteration in the binding of a specific protein/protein complex to a short region of the promoter of the human heme oxygenase 1 gene. Nucleic Acids Res 21:1103–1109. Paisán-Ruíz C, Jain S, Evans EW, Gilks WP, Simón J, van der Brug M, López de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Martí-Massó JF, Pérez-Tur J, Wood NW, Singleton AB. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 44:595-600. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 441:1157-1161. Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD. (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm. 104:661-677. Perry TL, Godin DV, Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett. 33:305-310. Perry TL, Yong VW. (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett. 67:269-274. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem. 280:34025-34032. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol. 9:1243-1252. Poirier LJ, Sourkes TL. (1965) Influence of the substantia nigra on the catecholamine content of the striatum. Brain. 88:181-92. Polymeropoulos MH. (2000) Genetics of Parkinson's disease. Ann N Y Acad Sci. 920:28-32. Pridgeon JW, Olzmann JA, Chin LS, Li L. (2007) PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol. 5:e172. Sawa A, Khan AA, Hester LD, Snyder SH. (1997) Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A. 94:11669-11674. Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Novère N, Obeso JA, Schwarzschild MA, Spampinato U, Davidai G. (2006) Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov. 5:845-854. Schipper HM, Liberman A, and Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease. Exp Neurol 150:60–68. Schipper HM. (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med. 37:1995-2011. Shibahara S, Muller M, and Taguchi H (1987) Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem 262:12889–12892. Shibahara S. (2003) The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med. 200:167-186. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem. 59:99-106. Stokes AH, Hastings TG, Vrana KE. (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res. 55:659-665. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046. Stout DL, and Becker FF (1986) Heme enzyme patterns in genetically and chemically induced mouse liver tumors. Cancer Res 46:2756–2759. Tang B, Xiong H, Sun P, Zhang Y, Wang D, Hu Z, Zhu Z, Ma H, Pan Q, Xia JH, Xia K, Zhang Z. (2006) Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet. 15:1816-1825. Taylor RC, Cullen SP, Martin SJ. (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 9:231-241. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, and Connor J (2003) Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 71:46–63. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 304:1158-1160. Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, Oldham S, Xia K, Wang J, Bodmer R, Zhang Z. (2006) Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A. 103:13520-13525. Williams JR, Little JB, Shipley WU. (1974) Association of mammalian cell death with a specific endonucleolytic degradation of DNA. Nature. 252:754-755. Wood-Kaczmar A, Gandhi S, Wood NW. (2006) Understanding the molecular causes of Parkinson's disease. Trends Mol Med. 12:521-528. Wyllie AH, Kerr JF, Currie AR. (1980) Cell death: the significance of apoptosis. Int Rev Cytol. 68:251-306. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A. 103:10793-10798. Yasuhara S, Zhu Y, Matsui T, Tipirneni N, Yasuhara Y, Kaneki M, Rosenzweig A, Martyn JA. (2003) Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis. J Histochem Cytochem. 51:873-885. Yoshida T, Biro P, Cohen T, Muller RM, and Shibahara S (1988) Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem 171:457–461. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Müller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 44:601-607. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26781 | - |
dc.description.abstract | 巴金森氏症是當今最常見的神經退化性疾病之一,以目前的藥物治療上只能緩解症狀而不能根除。目前對於其神經退化的致病機轉仍不清楚。Pink1是早發性巴金森氏症的隱性基因,Pink1的突變與否對早發性巴金森氏症來說非常重要。我們在SH-SY5Y中,做了Pink1變異的三個G309D clones和二個P209A clones共五個mutant stable clones,並和wild-type比較,發現用H2O2所引發的細胞內ROS的增加或細胞的凋亡,Pink1 mutant stable clones都有明顯的增加現象。而在dopamine uptake方面,給予H2O2後,Pink1 mutant stable clones的dopamine uptake減少的比wild-type更為明顯。另外利用BrdU Assay發現Pink1 mutant stable clones的增生速率要比wild-type慢很多。
Heme oxygenase 1 (HO-1) 是細胞遇到氧化壓力時產生的一個細胞保護分子,我們因此觀察了細胞經由H2O2所引發的HO-1的變化。在mRNA的部份,wild-type在一般情況的含量較低,但卻很容易被H2O2所引發 ; 而Pink1 mutant stable clones中的一些clones雖然在靜止狀態中的含量較高,但是在給予H2O2後HO-1 mRNA卻完全無法被引發。而在HO-1蛋白的部分則有類似的情況。接著我們用virus infection的方法使SH-SY5Y大量表現HO-1蛋白,發現Pink1 mutant stable clones經由H2O2所造成的細胞凋亡加速現象可以被拮抗。根據以上的結果,我們推測Pink1在細胞內的作用機制可能和HO-1有關,Pink1有可能參與了HO-1的引發路徑。此外,我們也觀察了細胞經由H2O2所引發的BDNF mRNA的變化。我們發現到大部份的Pink1 mutant stable clones在basal condition下的BDNF mRNA level都比wild-type高 ; 而給予H2O2後則在wild-type或是Pink1 mutant stable clones中都可以看到BDNF mRNA level下降的現象。我們初步推測BDNF似乎不是影響Pink1 mutant stable clones在遭受刺激後提升apoptotic rate的因子。 我們的結果發現Pink1在G309D或P209A產生變異均會提高其對H2O2引起的細胞凋亡之敏感性,而且氧化壓力引起的HO-1產生也被抑制。HO-1的產生受抑制可能與增加氧化壓力引起的細胞凋亡有關。 | zh_TW |
dc.description.abstract | Parkinson’s disease is one of the most common neurodegenerative diseases. However, the etiology is still not clear. Pink1 is the autosomal recessive gene of the early onset Parkinson’s disease (EOPD), and its mutation counts for much to EOPD. We established five Pink1mutant stable clones in SH-SY5Y: three clones for G309D and two clones for P209A. It was found that more ROS increased in mutant cell lines in response to H2O2 treatment. The apoptotic rate was increased in both G309D and P209A mutant stable clones following H2O2 treatment. Furthermore, Pink1 mutant stable clones had a lower level of dopamine uptake than wild-type after H2O2 treatment. BrdU assay showed that Pink1 mutant stable clones proliferated at a lower rate than that of wild-type.
Heme oxygenase 1 (HO-1) usually increases and exerts cell protection when the cells are under oxidative stress. HO-1 increased in wild-type cells following H2O2 treatment. However Pink1 mutant stable clones had a higher basal level of HO-1 and HO-1 can not be induced in response to H2O2 treatment. Using adenovirus infection to overexpress HO-1 and it was found that the H2O2-induced apoptotic rate in Pink1 mutant stable clones can be reversed. These results suggest that the neuroprotective role of Pink1 may have some signaling interaction with HO-1 in SH-SY5Y. Pink1 may be involved in HO-1 induction. On the other hand, it was found that the BDNF mRNA levels are much higher in Pink1 mutant stable clones than in wild-type in resting condition. Following H2O2 treatment, BDNF mRNA was inhibited in both wild-type and Pink1 mutant stable clones. Our results indicate that Pink1 mutant increase the apoptotic sensitivity to H2O2 treatment, and suppression of HO-1 induction but not BDNF production may be involved in the increase of neurotoxicity following oxidative stress. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T07:25:18Z (GMT). No. of bitstreams: 1 ntu-97-R95443015-1.pdf: 4345522 bytes, checksum: 45fd523742554088a1f009fdeade306a (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書...........................................2
謝辭.......................................................3 縮寫表.....................................................4 英文摘要...................................................6 中文摘要...................................................7 緒論......................................................10 實驗材料及方法............................................28 結果......................................................33 討論......................................................55 結論......................................................63 參考文獻..................................................64 | |
dc.language.iso | zh-TW | |
dc.title | SH-SY5Y中Pink1的神經保護作用之探討 | zh_TW |
dc.title | Neuroprotective action of Pink1 in SH-SY5Y neuroblastoma cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 劉宏輝(Horng-Huei Liou),楊春茂(Chuen-Mao Yang),王家儀(Jia-Yi Wang),李銘仁(Ming-Jen Lee) | |
dc.subject.keyword | 巴金森氏症, | zh_TW |
dc.subject.keyword | Pink1,HO-1, | en |
dc.relation.page | 75 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2008-07-16 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 4.24 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。